Expansion of personalized medicine approaches that require detailed genetic information to tailor treatments to individual patients, thereby driving the demand for genotyping assays. , /PRNewswire/ -- The genotyping assays market was projected to attain in 2023. It is likely to garner a 22.
5% CAGR from 2024 to 2034, and by 2034, the market is expected . Broadened applications of genotyping in areas such as drug discovery, agriculture, forensic science, and animal breeding. Adoption of AI and machine learning in data analysis, improving the efficiency and accuracy of genotyping assays.
Rising popularity of DTC genetic testing kits that allow consumers to access genetic information without the need for a healthcare provider, driving market growth. Development of automated and miniaturized genotyping platforms that offer high throughput and ease of use. Growing research focus on rare diseases, leading to the development of specialized genotyping assays for their detection and study.
Expanding applications in agriculture for crop and livestock improvement, which could open new revenue streams. Increased focus on cancer genotyping for precision oncology, enabling better-targeted therapies and improving patient outcomes. Growth in non-invasive prenatal testing, which uses genotyping assays to detect fetal genetic abnormalities.
Advancements in regenerative medicine and stem cell research requiring detailed genetic analysis, thereby boosting demand for genotyping assays. The rising .